Number 405745), CD1d (Cat
GLP-1s are serious medications with certain potential toxicities for some patients, including pancreatitis, thyroid cancer, and very rarely, but now officially acknowledged in the case of Wegovy blindness, caused by a condition called non-arteritic anterior ischemic optic neuropathy (NAION)
Other research investigating gastrointestinal motility has used doses near 1 mg/kg in rodent models to assess effects on gastric emptying and intestinal motility
FDA Concerns Surrounding Compounded GLP-1 In a May 16, 2025 statement, the U.S
Excellent range of chemicals and Excellent range of chemicals and buffers combined with great service and pricing
The CEO believes theres something to be said for size